跳至主要内容
临床试验/CTRI/2020/12/029534
CTRI/2020/12/029534尚未招募未知

A cross-sectional study on impact of CYP2C8 and CYP3A4 activity on pharmacokinetic variability of paclitaxel in chemotherapy naïve cancer patients

All India Institute of Medical Sciences Rishikesh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All chemotherapy naïve patients of malignancy.
  • Patients of malignancy planned to be treated with paclitaxel.
  • Patients of malignancy considered fit for chemotherapy will be enrolled in this study
  • Patients above 18 years of age
  • Patients willing to provide written informed consent

排除标准

  • Deranged renal function (serum creatinine level >= 1.5 mg/dL),
  • Concomitant radiotherapy for primary or metastatic sites;
  • Any other drugs known to induce or inhibit CYP3A4 or CYP2C8 enzyme

研究者

相似试验